Fatigue among short- and long-term thyroid cancer survivors: Results from the population-based PROFILES registry

Thyroid

Volumn 23, Issue 10, 2013, Pages 1247-1255

  Husson, Olga ^a,b   Nieuwlaat, Willy Anne ^c   Oranje, Wilma A ^c   Haak, Harm R ^d   Van De Poll Franse, Lonneke V ^a,b   Mols, Floortje ^a,b  

^a TILBURG UNIVERSITY   (Netherlands)

^b The Netherlands   (Netherlands)

^c CPRLab   (Netherlands)

^d MÁXIMA MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY DISORDER; CANCER SURVIVOR; COMORBIDITY; CONFERENCE PAPER; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; DISTRESS SYNDROME; DYSTHYMIA; EMPLOYMENT STATUS; FATIGUE; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; THYROID CANCER;

ADULT; AGED; ANXIETY; COGNITION DISORDERS; COHORT STUDIES; COMBINED MODALITY THERAPY; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DEPRESSION; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; NEUROMUSCULAR DISEASES; PREVALENCE; QUALITY OF LIFE; REGISTRIES; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL; SURVIVORS; THYROID NEOPLASMS;

EID: 84884614924     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2013.0015     Document Type: Conference Paper

References (47)

1. Colonna M, Bossard N, Guizard AV, Remontet L, Grosclaude P 2010 Descriptive epidemiology of thyroid cancer in France: incidence, mortality and survival. Ann Endocrinol (Paris) 71:95-101.
2. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BKe 2010 SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD.
3. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167.
4. Pacini F, Castagna MG, Brilli L, Pentheroudakis G 2010 Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21 Suppl 5:v214-v219.
5. Links TP, Huysmans DA, Smit JW, de Heide LJ, Hamming JF, Kievit J, van Leeuwen M, van Pel R, de Klerk JM, van der Wel Y 2007 [Guideline "Differentiated thyroid carcinoma, " including diagnosis of thyroid nodules]. Ned Tijdschr Gen-eeskd 151:1777-1782.
6. Cella D, Davis K, Breitbart W, Curt G 2001 Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19:3385-3391.
7. Campos MP, Hassan BJ, Riechelmann R, Del Giglio A 2011 Cancer-related fatigue: a practical review. Ann Oncol 22:1273-1279.
8. Servaes P, Verhagen C, Bleijenberg G 2002 Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer 38:27-43.
9. Gupta D, Lis CG, Grutsch JF 2007 The relationship between cancer-related fatigue and patient satisfaction with quality of life in cancer. J Pain Symptom Manage 34:40-47.
10. Barsevick A, Frost M, Zwinderman A, Hall P, Halyard M 2010 I'm so tired: biological and genetic mechanisms of cancer-related fatigue. Qual Life Res 19:1419-1427.
11. Fossa SD, Dahl AA, Loge JH 2003 Fatigue, anxiety, and depression in long-term survivors of testicular cancer. J Clin Oncol 21:1249-1254.
12. Reinertsen KV, Cvancarova M, Loge JH, Edvardsen H, Wist E, Fossa SD 2010 Predictors and course of chronic fatigue in long-term breast cancer survivors. J Cancer Surviv 4:405-414.
13. Singer S, Lincke T, Gamper E, Bhaskaran K, Schreiber S, Hinz A, Schulte T 2012 Quality of life in patients with thyroid cancer compared with the general population. Thyroid 22:117-124.
14. Lee JI, Kim SH, Tan AH, Kim HK, Jang HW, Hur KY, Kim JH, Kim KW, Chung JH, Kim SW 2010 Decreased health-related quality of life in disease-free survivors of differentiated thyroid cancer in Korea. Health Qual Life Outcomes 8:101.
15. Hoftijzer HC, Heemstra KA, Corssmit EP, van der Klaauw AA, Romijn JA, Smit JW 2008 Quality of life in cured patients with differentiated thyroid carcinoma. J Clin En-docrinol Metab 93:200-203.
16. Eustatia-Rutten CF, Corssmit EP, Pereira AM, Frolich M, Bax JJ, Romijn JA, Smit JW 2006 Quality of life in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomized controlled trial. Clin Endocrinol (Oxf) 64:284-291.
17. Gning I, Trask PC, Mendoza TR, Harle MT, Gutierrez KA, Kitaka SA, Sherman SI, Cleeland CS 2009 Development and initial validation of the thyroid cancer module of the M. D. Anderson Symptom Inventory. Oncology 76:59-68.
18. Taieb D, Sebag F, Cherenko M, Baumstarck-Barrau K, For-tanier C, Farman-Ara B, De Micco C, Vaillant J, Thomas S, Conte-Devolx B, Loundou A, Auquier P, Henry JF, Mundler O 2009 Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study. Clin Endocrinol (Oxf) 71: 115-123.
19. Huang SM, Lee CH, Chien LY, Liu HE, Tai CJ 2004 Postoperative quality of life among patients with thyroid cancer. J Adv Nurs 47:492-499.
20. Mendoza A, Shaffer B, Karakla D, Mason ME, Elkins D, Goffman TE 2004 Quality of life with well-differentiated thyroid cancer: treatment toxicities and their reduction. Thyroid 14:133-140.
21. Kaltsas G, Vgontzas A, Chrousos G 2010 Fatigue, en-docrinopathies, and metabolic disorders. PM R 2:393-398.
22. Janssen-Heijnen MLG, Louwman WJ, Van de Poll-Franse LV, Coebergh JWW 2005 Results of 50 Years Cancer Registry in the South of The Netherlands: 1955-2004 (in Dutch). Eindhoven Cancer Registry, Eindhoven, The Netherlands.
23. van de Poll-Franse LV, Horevoorts N, Eenbergen MV, De-nollet J, Roukema JA, Aaronson NK, Vingerhoets A, Coe-bergh JW, de Vries J, Essink-Bot ML, Mols F 2011 The patient reported outcomes following initial treatment and long term evaluation of survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer 47:2188-2194.
24. International Union Against Cancer (UICC) 2002 TNM Classification of Malignant Tumors, 6th ed. John Wiley and Sons, New Jersey.
25. Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN 2003 The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 49:156-163.
26. Zigmond AS, Snaith RP 1983 The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361-370.
27. Olsson I, Mykletun A, Dahl AA 2005 The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry 5:46.
28. Husson O, Haak HR, Mols F, Nieuwenhuijzen G, Nieuwlaat W, Reemst PH, Huysmans D, Toorians A, Van de PollFranse LV 2013 Development of a disease-specific health-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors. Acta Oncol 52:447-454.
29. Michielsen HJ, Drent M, Peros-Golubicic T, De Vries J 2006 Fatigue is associated with quality of life in sarcoidosis patients. Chest 130:989-994.
30. Michielsen HJ, De Vries J, Van Heck GL 2003 Psychometric qualities of a brief self-rated fatigue measure: The Fatigue Assessment Scale. J Psychosom Res 54:345-352.
31. Michielsen HJ, De Vries J, Drent M, Peros-Golubicic T 2005 Psychometric qualities of the Fatigue Assessment Scale in Croatian sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 22:133-138.
32. Michielsen HJ, Van der Steeg AF, Roukema JA, De Vries J 2007 Personality and fatigue in patients with benign or malignant breast disease. Support Care Cancer 15:1067-1073.
33. van de Poll-Franse LV, Mols F, Gundy CM, Creutzberg CL, Nout RA, Verdonck-de Leeuw IM, Taphoorn MJ, Aaronson NK 2011 Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population. Eur J Cancer 47:667-675.
34. Norman GR, Sloan JA, Wyrwich KW 2003 Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41:582-592.
35. Thong MS, Mols F, Wang XS, Lemmens VE, Smilde TJ, van de Poll-Franse LV 2013 Quantifying fatigue in (long-term) colorectal cancer survivors: a study from the population-based Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry. Eur J Cancer 49:1957-1966.
36. Oerlemans S, Mols F, Issa DE, Pruijt JH, Peters WG, Lybeert M, Zijlstra W, Coebergh JW, van de Poll-Franse LV 2013 A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands. Haematologica 98:479-486.
37. Husson O, Haak HR, Buffart LM, Nieuwlaat W, Oranje WA, Mols F, Kuijpens JL, Coebergh JW, Van de Poll-Franse LV 2013 Health-related quality of life and disease specific symptoms among (long-term) thyroid cancer survivors: a study from the population-based PROFILES registry. Acta Oncol 52:249-258.
38. Andersen S, Pedersen KM, Bruun NH, Laurberg P 2002 Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 87:1068-1072.
39. Regalbuto C, Maiorana R, Alagona C, Paola RD, Cianci M, Alagona G, Sapienza S, Squatrito S, Pezzino V 2007 Effects of either LT4 monotherapy or LT4/LT3 combined therapy in patients totally thyroidectomized for thyroid cancer. Thyroid 17:323-331.
40. Campos MP, Hassan BJ, Riechelmann R, Del Giglio A 2011 Cancer-related fatigue: a review. Rev Assoc Med Bras 57:211-219.
41. Mock V, Atkinson A, Barsevick A, Cella D, Cimprich B, Clee-land C, Donnelly J, Eisenberger MA, Escalante C, Hinds P, Ja-cobsen PB, Kaldor P, Knight SJ, Peterman A, Piper BF, Rugo H, Sabbatini P, Stahl C 2000 NCCN Practice Guidelines for Cancer-Related Fatigue. Oncology (Williston Park) 14:151-161.
42. Parker KP, Bliwise DL, Ribeiro M, Jain SR, Vena CI, KohlesBaker MK, Rogatko A, Xu Z, Harris WB 2008 Sleep/Wake patterns of individuals with advanced cancer measured by ambulatory polysomnography. J Clin Oncol 26: 2464-2472.
43. Cleeland CS, Bennett GJ, Dantzer R, Dougherty PM, Dunn AJ, Meyers CA, Miller AH, Payne R, Reuben JM, Wang XS, Lee BN 2003 Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-im-munologic model of cancer symptoms. Cancer 97:2919-2925.
44. Collado-Hidalgo A, Bower JE, Ganz PA, Cole SW, Irwin MR 2006 Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 12:2759-2766.
45. Orre IJ, Fossa SD, Murison R, Bremnes R, Dahl O, Klepp O, Loge JH, Wist E, Dahl AA 2008 Chronic cancer-related fatigue in long-term survivors of testicular cancer. J Psycho-som Res 64:363-371.
46. Escalante CP, Manzullo EF 2009 Cancer-related fatigue: the approach and treatment. J Gen Intern Med 24 Suppl 2:S412-S416.
47. Yun YH, Lee KS, Kim YW, Park SY, Lee ES, Noh DY, Kim S, Oh JH, Jung SY, Chung KW, Lee YJ, Jeong SY, Park KJ, Shim YM, Zo JI, Park JW, Kim YA, Shon EJ, Park S 2012 Web-based tailored education program for disease-free cancer survivors with cancer-related fatigue: a randomized controlled trial. J Clin Oncol 30:1296-1303.